Philip Morris International NYSE:PM, a global tobacco and smoke-free nicotine-products company, doubled its planned investment in a Colorado manufacturing campus to approximately $1.2 billion through 2028. The company is expanding production capacity for Zyn nicotine pouches, which have become the fastest-growing nicotine-product category in the United States and are used by millions of consumers. Philip Morris originally announced a $600 million investment in 2024 to construct the Aurora manufacturing facility. The plant officially opened on Monday, giving the company additional capacity to serve domestic demand and export markets as it continues expanding its portfolio of products that do not require cigarette combustion.
The Aurora plant manufactures Zyn nicotine pouches and is expected to support exports across Asia, Latin America and the Caribbean. Once fully operational, Philip Morris expects the facility to generate approximately $550 million in annual economic activity and support 1,000 indirect jobs. The Colorado campus joins the company's existing modern oral-nicotine manufacturing operations in Owensboro, Kentucky, and Wilson, North Carolina. The additional investment could strengthen Philip Morris' ability to increase supply, although Reuters did not provide the campus's expected production volume or specify how much revenue the facility could contribute directly to the company.
The expansion follows the U.S. Food and Drug Administration's authorization of 20 Zyn nicotine-pouch products several weeks earlier. The authorization allows Philip Morris to market information indicating that the products are less harmful than cigarettes, although it does not mean they are risk-free. Demand for Zyn has contributed to Philip Morris' sales and broader growth across smoke-free products, including IQOS heated-tobacco devices and vaping products. The company exceeded analysts' second-quarter expectations in July, supported by strong demand for its smoke-free portfolio. Investors may view the increased Colorado commitment as evidence that management expects nicotine-pouch demand to continue supporting growth. However, the financial return will depend on production utilization, consumer demand, regulatory conditions and the company's ability to expand distribution across the identified international markets.